182 related articles for article (PubMed ID: 32037354)
1. Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.
Han Y; Igawa T; Ogino K; Nishikori A; Gion Y; Yoshino T; Sato Y
J Clin Exp Hematop; 2020 Mar; 60(1):1-6. PubMed ID: 32037354
[TBL] [Abstract][Full Text] [Related]
2. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease.
Manabe A; Igawa T; Takeuchi M; Gion Y; Yoshino T; Sato Y
Med Mol Morphol; 2017 Mar; 50(1):34-41. PubMed ID: 27438709
[TBL] [Abstract][Full Text] [Related]
4. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
[TBL] [Abstract][Full Text] [Related]
5. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
[TBL] [Abstract][Full Text] [Related]
6. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
7. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
[No Abstract] [Full Text] [Related]
8. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
[TBL] [Abstract][Full Text] [Related]
9. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.
Zoshima T; Yamada K; Hara S; Mizushima I; Yamagishi M; Harada K; Sato Y; Kawano M
Am J Surg Pathol; 2016 Apr; 40(4):495-501. PubMed ID: 26598921
[TBL] [Abstract][Full Text] [Related]
10. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Doai M; Matoba M; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Mizumaki H; Yamaguchi M; Masaki Y
Intern Med; 2019 Sep; 58(17):2555-2560. PubMed ID: 31178507
[TBL] [Abstract][Full Text] [Related]
12. IgG4-related lymphadenopathy.
Cheuk W; Bledsoe JR
Semin Diagn Pathol; 2024 Mar; 41(2):108-115. PubMed ID: 38228439
[TBL] [Abstract][Full Text] [Related]
13. IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels.
Ikeura T; Horitani S; Masuda M; Kasai T; Yanagawa M; Miyoshi H; Uchida K; Takaoka M; Miyasaka C; Uemura Y; Okazaki K
Intern Med; 2016; 55(18):2623-8. PubMed ID: 27629957
[TBL] [Abstract][Full Text] [Related]
14. HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease.
Kawano M; Hara S; Yachie A; Inoue D; Sato Y; Fajgenbaum DC
Rheumatology (Oxford); 2021 Jan; 60(1):e3-e4. PubMed ID: 32772106
[No Abstract] [Full Text] [Related]
15. IgG4-related respiratory disease.
Matsui S
Mod Rheumatol; 2019 Mar; 29(2):251-256. PubMed ID: 30474465
[TBL] [Abstract][Full Text] [Related]
16. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
[TBL] [Abstract][Full Text] [Related]
17. Castleman disease of plasma cell type accompanied with bronchiolitis obliterans: a case report and review of the literature.
Zhu Q; Wang S
J Med Case Rep; 2023 Dec; 17(1):539. PubMed ID: 38082371
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.
Kasashima S; Kawashima A; Kasashima F; Endo M; Matsumoto Y; Kawakami K
Heart Vessels; 2018 Dec; 33(12):1471-1481. PubMed ID: 29931542
[TBL] [Abstract][Full Text] [Related]
19. IgG4-related disease involving polyserous effusions with elevated serum interleukin-6 levels: a case report and literature review.
Tong X; Bai M; Wang W; Han Q; Tian P; Fan H
Immunol Res; 2017 Aug; 65(4):944-950. PubMed ID: 28710703
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
